Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
STONY BROOK, NY / ACCESSWIRE / May 10, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),...
News
Akanda Corp. Announces Plans to Be Among International First Movers Pending Completion of Landmark Change in US Drug Policy
London, United Kingdom--(Newsfile Corp. - May 10, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical...
Next Level Mobility Recognizes National Mobility Awareness Month, Promoting Healthier Lifestyles and Accessibility
MURRELLS INLET, SC / ACCESSWIRE / May 10, 2024 / May marks National Mobility Awareness Month, a time to celebrate...
ŌURA Announces Two New Heart Health Features, Moving Deeper into Preventative Health
New Cardiovascular Age and Cardio Capacity capabilities further establish ŌURA as a personal health companion for improving healthspan and longevitySAN...
Scientific Industries to Host First Quarter 2024 Financial Results Investor Call on May 16, 2024
Investor Call to be held at 11:00 AM Eastern Time BOHEMIA, NY / ACCESSWIRE / May 10, 2024 / Scientific...
Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European Markets
- Distributors appointed in France, the United Kingdom, and Italy - Industry veteran Enrico Barini joins as International Business Development...
MDI Health Wins Best New Technology Solution for Medication Management Award
8th Annual MedTech Breakthrough Awards, Prestigious Annual Awards Program Honors Standout Digital Health & Medical Technology Products and CompaniesLOS ANGELES--(BUSINESS...
Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for “Best Overall Mental Health Solution”
This marks the fourth consecutive year that Castle has earned a MedTech Breakthrough Award for its innovative testing solutionsFRIENDSWOOD, Texas--(BUSINESS...
TruBridge Announces First Quarter 2024 Results
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced financial results for the first quarter ended March...
Veradigm Payerpath Rated Highest in Client Satisfaction for Small Physician Practice Clearinghouse Services, 2024 Black Book Survey
TAMPA, FL / ACCESSWIRE / May 10, 2024 / Black Book Research's annual poll of over 13,000 medical practice IT...
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
STONY BROOK, NY / ACCESSWIRE / May 10, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in...
The Plus SideZ: Ozempic Health & Wellness Educational Podcast Records Live Episode
Podcast Hosts TikTok Ozempic Creator Community Meet-UpATLANTA, GA / ACCESSWIRE / May 10, 2024 / The Plus Sidez: Cracking the...
Moderna Announces Update on Investigational RSV Vaccine
U.S. FDA has informed Moderna that due to administrative constraints, the agency will not complete its review of mRNA-1345 by...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City
SHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum...
Optimi Health Provides Corporate Update
VANCOUVER, British Columbia, May 10, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or...
Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology...
Genflow Biosciences PLC Announces Holding(s) in Company
LONDON, UK / ACCESSWIRE / May 10, 2024 / TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW...
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
Eversense® CGM+RPM solution to be powered by Rimidi’s clinical management platformGERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical...
HeartBeam Reports First Quarter 2024 Results
Continued Clinical and Regulatory Progress on the AIMIGo™ 3D VECG System Presented Positive Results on its Artificial Intelligence Capabilities for...
Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
Revenue growth of 31% driven by strong clinical and biopharma volume and Guardant360 ASP tailwindsPALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc....